Postmenopausal hormone therapy and age-related maculopathy in older women

Ophthalmic Epidemiology

Volumn 15, Issue 5, 2008, Pages 308-316

  Seitzman, Robin L ^a,j   Mangione, Carol ^a   Ensrud, Kristine E ^b,c   Cauley, Jane A ^d   Stone, Katie L ^e   Cummings, Steven R ^e,f   Hochberg, Marc C ^g   Hillier, Teresa A ^h   Yu, Fei ^a,i   Coleman, Anne L ^a,i  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF MARYLAND   (United States)

^h CENTER FOR HEALTH RESEARCH   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j BIOGEN   (United States)

more..

Author keywords

Age related macular degeneration; Age related maculopathy; Estrogen; Postmenopausal hormone therapy

Indexed keywords

ESTROGEN; GESTAGEN;

AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FRAGILITY FRACTURE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; OPHTHALMOSCOPY; POSTMENOPAUSE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SCORING SYSTEM; SMOKING; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MACULAR DEGENERATION; ODDS RATIO; PROGESTINS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 53749088862     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580802077724     Document Type: Article

References (34)

1. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995;36:182-191.
2. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564-572.
3. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol. 1992;110:1701-1708.
4. Klein BE, Klein R, Jensen SC, Ritter LL. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 1994; 92: 289-95; discussion 295-297.
5. Klein BE, Klein R, Lee KE. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: The Beaver Dam Eye Study. Am J Ophthalmol. 2000;130(3):322-326.
6. Freeman EE, Munoz B, Bressler SB, West SK. Hormone replacement therapy, reproductive factors, and age-related macular degeneration: The Salisbury Eye Evaluation Project. Ophthalmic Epidemiol. 2005;12(1):37-45.
7. Haan MN, Klein R, Klein BE, Deng Y, Blythe LK, Seddon JM, Musch DC, Kuller LH, Hyman LG, Wallace RB. Hormone therapy and age-related macular degeneration: The Women's Health Initiative Sight Exam Study. Arch Ophthalmol. 2006;124(7):988-92.
8. Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: Results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol. 1997; 25 Suppl 1: S13-15.
9. Vingerling JR, Dielemans I, Witteman JC, Hofman A, Grobbee DE, de Jong PT. Macular degeneration and early menopause: A case-control study. BMJ 1995; 310(6994):1570-1571.
10. Boekhoorn SS, Vingerling JR, Uitterlinden AG, Van Meurs JB, van Duijn CM, Pols HA, Hofman A, de Jong PT. Estrogen receptor alpha gene polymorphisms associated with incident aging macular disorder. Invest Ophthalmol Vis Sci. 2007;48(3):1012-7.
11. Snow KK, Cote J, Yang W, et al. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol. 2002; 134(6): 842-848.
12. Abramov Y, Borik S, Yahalom C, et al. The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women. Menopause. 2004;11(1):62-68.
13. Klein R, Klein BE, Jensen SC, Meuer SM. The 5-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. 1997; 104(1):7-21.
14. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001;108(4):697-704.
15. Mitchell P, Wang JJ, Smith W, Leeder SR. Smoking and the 5-year incidence of age-related maculopathy: The Blue Mountains Eye Study. Arch Ophthalmol. 2002; 120(10):1357-1363.
16. Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l'Age. Arch Ophthalmol. 1998;116(8): 1031-1035.
17. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol. 1996;114(12):1518-1523.
18. Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: The relation of age-related maculopathy to smoking. Am J Epidemiol. 1993; 137(2):190-200.
19. Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol. 1996; 114(10):1193-1196.
20. Fraser-Bell S, Wu J, Klein R, Azen S, Varma R. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: The Los Angeles Latino Eye Study. Am J Ophthalmol. 2006 Jan;141(1):79-87.
21. Tanko LB, Christiansen C. An update on the antiestrogenic effect of smoking: A literature review with implications for researchers and practitioners. Menopause. 2004;11(1):104-109.
22. Klein R, Davis MD, Magli YL, et al. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology. 1991; 98(7):1128-1134.
23. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in amultiracial United States population: The National Health and Nutrition Examination Survey III. Ophthalmology. 1999;106(6):1056-1065.
24. Klein R, Klein BE, Jensen SC, Cruickshanks KJ. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 1998;116:506-513.
25. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons Inc; 1987.
26. Schafer JL. Analysis of Incomplete Multivariate Data. New York: Chapman and Hall/CRC; 1997.
27. Defay R, Pinchinat S, Lumbroso S, Sutan C, Delcourt C; Pola Study Group. Sex steroids and age-related macular degeneration in older French women: The POLA study. Ann Epidemiol. 2004;14(3):202-208.
28. Seitzman RL, Mangione CM, Cauley JA, Ensrud KE, Stone KL, Cummings SR, Hochberg MC, Hillier TA, Yu F, Coleman AL; Study of Osteoporotic Fractures Research Group. Bone mineral density and age-related maculopathy in older women. J Am Geriatr Soc. 2007;55(5):740-6.
29. Jensen J, Christiansen C, Rødbro P. Cigarette smoking, serum estrogens, and bone loss during hormone replacement therapy early after menopause. N Engl J Med. 1985; 313:973-975.
30. Jensen J, Christiansen C. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Am J Obstet Gynecol. 1988;159:820-825.
31. Geisler J, Omsjo IH, Helle SI, Ekse D, Silsand T, Lonning PE. Plasma estrogen fractions in postmenopausal women receiving hormone replacement therapy: Influence of route of administration and cigarette smoking. J Endocrinol. 1999;162:265-270.
32. Cassidenti DL, Vijod AG, Vijod MA, Stanczyk FZ, Lobo RA. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. Am J Obstet Gynecol. 1990; 163:1953-1960.
33. Bjarnason NH, Christiansen C. The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women. J Clin Endocrinol Metab. 2000; 85:590-596.
34. Kiel DP, Baron JA, Anderson JJ, Hannan MT, Felson DT. Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women. Ann Intern Med. 1992;116:716-721.